ArticleAnnals of medicine and surgery (2012)2022

Sodium-glucose Co-transporter-2 inhibitors (SGLT2I): A class of drugs with promising cardiorenal protective effects beyond glycemic control.

Abdullah Zaawari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.